Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart attack recovery goes remote: video exercise may boost rehab attendance

NCT ID NCT04260958

Disease control Sponsor: Sahlgrenska University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial tests whether offering remote video exercise sessions, as an alternative to center-based rehab, helps more people attend cardiac rehabilitation after a heart attack. About 1,500 adults aged 18–79 who had a type 1 heart attack will be assigned to either remote or center-based exercise programs. The study measures how many sessions participants complete over four months, aiming to see if the remote option improves attendance and recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
exercise-based cardiac rehabilitation (remote or center-based)
What this could lead to
If successful, this could offer a flexible, remote option for cardiac rehab, potentially increasing participation and improving recovery after a heart attack.
What could go wrong
This is a large trial, but results depend on patient adherence and technology access; remote rehab may not suit everyone, and the study does not test new drugs or devices.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2020

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 79 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Written informed consent * Diagnosis of type 1 myocardial infarction (AMI) * Age 18-79 years at discharge from hospital Exclusion Criteria: * Patients with incomplete coronary revascularization defined as at least one remaining hemodynamically significant stenosis * Severe valve or structural heart disease * Severe heart failure (NYHA III - IV) * Serious arrythmias * Inability to understand Swedish * No internet access at home (only applicable for patients in the intervention group who wants to perform remote exCR) * Pathological exercise test indicating high risk for adverse events during exCR * More than 6 months between discharge form hospital and screening * Any other condition that may interfere with the possibility for the patient to comply with the study protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myocardial infarction are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Myocardial infarction

Contacts and locations

Locations

  • Angered Hospital

    Gothenburg, Sweden

  • Capio St Göran Hospital

    Stockholm, Sweden

  • Falun hospital

    Falun, Sweden

  • Gällivare Hospital

    Gällivare, Sweden

  • Gävle Hospital

    Gävle, Sweden

  • Hässleholm Hospital

    Hässleholm, Sweden

  • Jönköping Ryhov hospital

    Jönköping, Sweden

  • Kalix hospital

    Kalix, Sweden

  • Kalmar Hospital

    Kalmar, Sweden

  • Karolinska University Hospital

    Stockholm, Sweden

  • Kungälv Hospital

    Kungälv, Sweden

  • Lindesberg Hospital

    Lindesberg, Sweden

  • Linköping University Hospital

    Linköping, Sweden

  • Ljungby Hospital

    Ljungby, Sweden

  • Mälarsjukhuset

    Eskilstuna, Sweden

  • Sahlgrenska University Hospital

    Gothenburg, Sweden

  • Sahlgrenska University Hospital Östra

    Gothenburg, Sweden

  • Skåne University Hospital Malmö

    Malmö, Sweden

  • Skåne University hospital

    Lund, Sweden

  • Sunderbyn hospital

    Luleå, Sweden

  • Sundsvall hospital

    Sundsvall, Sweden

  • Södra Älvsborg Hospital

    Borås, Sweden

  • Uppsala University Hopsital

    Uppsala, Sweden

  • Värnamo hospital

    Värnamo, Sweden

  • Östersund hospital

    Östersund, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.